Thus, no definitive conclusions regarding its usefulness as a biomarker for CMT1A can be made based on this relatively small sample set, but the sample is useful for the comparison of rare cases of advanced CMT1E to CMT1A. Here, PMP22 is linked to Charcot-Marie-Tooth disease type 1E.